Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Heidelberg University
University Hospital, Rouen
Thomas Jefferson University
Sykehuset Innlandet HF
Calibr, a division of Scripps Research
Canadian Cancer Trials Group
University of Michigan